Syndax Pharmaceuticals Garners $4,947,480 New Round

  • Feed Type
  • Date
    9/22/2014
  • Company Name
    Syndax Pharmaceuticals
  • Mailing Address
    400 Totten Pond Road Waltham, MA 02451 USA
  • Company Description
    Syndax Pharmaceuticals, Inc. is a Waltham, MA-based, oncology-focused biotechnology company that is building a portfolio of new oncology products to extend and improve the lives of patients by developing and commercializing novel cancer therapies in optimized, mechanistically driven combination regimens.
  • Website
    http://www.syndax.com
  • Transaction Type
    Debt
  • Transaction Amount
    $4,947,480
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy